Obermatt
See Similar Stocks →

Solventum

NYQ:SOLV · US83444M1018
Health Care Equipment & SuppliesX-Large

360

62
EV / EBIT78
Price / Owner Earnings59
Owner Earnings Yield92
Dividend Yield1
Price/Sales61
EV / Gross Profit62
Price/Book38
Return on Capital49
Cash Return on Capital94
Return on Equity100
EBIT Margin43
Gross Profitability52
Cash Conversion1
Accruals85
Owner Earnings Margin94
Sales growth15
Profit Growth91
Long-Term EPS Growth53
Owner Earnings Growth94
Reinvestment54
Price momentum56
Debt load25
Refinancing15
Debt Payback48
Liquidity56
Analyst ratings16
Opinion Changes72
Price Target Upside16
Market mood73
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Solventum clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
TypePublic Company
ExchangeNYSE
Founded2023
Employees9,099
Websitesolventum.com/en-us/home
ISINUS83444M1018
Last UpdateApr 2, 2026
Indices
S&P 500 (USA)D.J. US Health Care
Themes
Biomedical EngineeringHealth DiagnosticsDentistryHealth CareMedicalPersonal Health

Description

Solventum Corporation (Solventum) is a major global healthcare company. The company is developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to addr…

Analysis

Middle-of-the-road

Solventum Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is attractive. You pay 8.7× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -5% yearly growth; analysts expect 10%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is stretched. The company scores 12/20 on our value-creation score: creating some value.

What to watch: Some accounting patterns deserve a closer look. The financial cushion is thinner than comfortable. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
25
2026

All-time high

25

Jun 2026

All-time low

6

Mar 2026

Average rank

16

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
61
—
—
—
Price/Earnings
46
—
—
—
Price/Book
38
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
37
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Solventum with its peers
Varex Imaging
NSQ:VREX
43
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
KORU Medical Systems
NAQ:KRMD
40
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
CVRx
NSQ:CVRX
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Sensus Healthcare
NAQ:SRTS
54
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Penumbra
NYQ:PEN
60
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Apyx Medical
NSQ:APYX
34
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →